Successful Outcome of Human Metapneumovirus (hMPV) Pneumonia in a Lung Transplant Recipient Treated With Intravenous Ribavirin

Human metapneumovirus (hMPV) has recently been shown to be a prominent cause of respiratory infections in immunocompromised hosts, and is associated with high morbidity and mortality. We report a case of hMPV pneumonia in a lung transplant recipient presenting with respiratory failure and sepsis syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Kashif, Ismailjee, Sameer B., Crespo, Maria, Studer, Sean M., Sanghavi, Sonali, Paterson, David L., Kwak, Eun J., Rinaldo, Charles R., Pilewski, Joseph M., McCurry, Kenneth R., Husain, Shahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. Published by Elsevier Inc. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111659/
https://www.ncbi.nlm.nih.gov/pubmed/17692793
http://dx.doi.org/10.1016/j.healun.2007.05.020
Descripción
Sumario:Human metapneumovirus (hMPV) has recently been shown to be a prominent cause of respiratory infections in immunocompromised hosts, and is associated with high morbidity and mortality. We report a case of hMPV pneumonia in a lung transplant recipient presenting with respiratory failure and sepsis syndrome. hMPV was diagnosed by polymerase chain reaction, and treated with intravenous ribavirin with a successful outcome.

Ejemplares similares